Document is current
Any future updates will be listed below
-
Authors
Dlouha, Dana
Wohlfahrt, Peter
Suchanek, Pavel
Hubacek, Jaroslav Alois
-
Funding
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (NU22-01-00151)
Ministerstvo Zdravotnictví Ceské Republiky (IN 00023001)
Institute for Clinical and Experimental Medicine
- License Information
-
More Information
Article History
Received: 22 August 2025
Revised: 30 October 2025
Accepted: 13 November 2025
First Online: 21 November 2025
Declarations
:
: The study was approved on 13 June 2018 (approval number G-18-52) and on August 10, 2022 (approval no. G-22-38) by the Ethics Committee of the Institute for Clinical and Experimental Medicine and Thomayer University Hospital in Prague, Czech Republic.
: The study was performed according to the Declaration of Helsinki (2000) of the World Medical Association. All patients signed informed consent forms for their involvement in the study. This consent grants permission to use their RNA anonymously for medical research purposes. The consent also states that testing results, including information about the participants' health status related to this research, may be presented at professional scientific conferences or published in journals without any identifying information or attribution.
: The authors declare no competing interests.
